Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

Maravai Lifesciences Holdings

06/08/2026 22:01

Maravai LifeSciences Holdings Inc MRVI.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -8 cents.  The mean expectation of eight analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -6 cents to -3 cents per share.
Revenue rose 8.5% to $51.44 million from a year ago; analysts expected $48.68 million. 
Maravai LifeSciences Holdings Inc's reported EPS for the quarter was a loss of 8 cents​.
The company reported a quarterly loss of $12.42 million.
Maravai LifeSciences Holdings Inc shares had risen by 2.7% this quarter and gained 97.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 8.7% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $6.00, about 6.8% below its last closing price of $6.41
This summary was machine generated from LSEG data August 6 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.04
-0.02
Beat
Mar. 31 2026 
-0.05
0.01
Beat
Dec. 31 2025 
-0.07
-0.04
Beat
Sep. 30 2025 
-0.08
-0.08
Met